These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 38547524

  • 1. Comparative Effectiveness and Safety of Intermittent, Repeated, or Continuous Use of Levosimendan, Milrinone, or Dobutamine in Patients With Advanced Heart Failure: A Network and Single-Arm Meta-analysis.
    Zhang X, Wang Z, Zhang L, Zhao X, Han Y.
    J Cardiovasc Pharmacol; 2024 Jul 01; 84(1):92-100. PubMed ID: 38547524
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure.
    Kelly J, Cheng J, Malloy R, Lupi K.
    J Cardiovasc Pharmacol; 2020 May 01; 75(5):455-459. PubMed ID: 32091426
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Repeated Levosimendan Infusions in the Management of Advanced Heart Failure: Review of the Evidence and Meta-analysis of the Effect on Mortality.
    Silvetti S, Pollesello P, Belletti A.
    J Cardiovasc Pharmacol; 2024 Feb 01; 83(2):144-157. PubMed ID: 37991393
    [Abstract] [Full Text] [Related]

  • 10. Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients.
    Milwidsky A, Frydman S, Laufer-Perl M, Sadeh B, Sapir O, Granot Y, Hochstadt A, Korotetski L, Ketchker L, Topilsky Y, Banai S, Havakuk O.
    ESC Heart Fail; 2022 Apr 01; 9(2):1487-1491. PubMed ID: 35083882
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of Levosimendan on cardiac function, size and strain in heart failure patients.
    Beitzke D, Gremmel F, Senn D, Laggner R, Kammerlander A, Wielandner A, Nolz R, Hülsmann M, Loewe C.
    Int J Cardiovasc Imaging; 2021 Mar 01; 37(3):1063-1071. PubMed ID: 33103224
    [Abstract] [Full Text] [Related]

  • 14. Long-term intravenous inotropes in low-output terminal heart failure?
    von Scheidt W, Pauschinger M, Ertl G.
    Clin Res Cardiol; 2016 Jun 01; 105(6):471-81. PubMed ID: 26879807
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with different blood BNP levels.
    Pan HY, Zhu JH, Gu Y, Yu XH, Pan M, Niu HY.
    BMC Cardiovasc Disord; 2014 Mar 04; 14():31. PubMed ID: 24593826
    [Abstract] [Full Text] [Related]

  • 17. Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment:A Randomized Double-Blind Controlled Trial.
    Lannemyr L, Ricksten SE, Rundqvist B, Andersson B, Bartfay SE, Ljungman C, Dahlberg P, Bergh N, Hjalmarsson C, Gilljam T, Bollano E, Karason K.
    J Am Heart Assoc; 2018 Aug 21; 7(16):e008455. PubMed ID: 30369310
    [Abstract] [Full Text] [Related]

  • 18. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
    Barraud D, Faivre V, Damy T, Welschbillig S, Gayat E, Heymes C, Payen D, Shah AM, Mebazaa A.
    Crit Care Med; 2007 May 21; 35(5):1376-82. PubMed ID: 17414729
    [Abstract] [Full Text] [Related]

  • 19. Network Meta-Analysis of the Safety of Drug Therapy for Cardiogenic Shock.
    Liao X, Qian L, Zhang S, Chen X, Lei J.
    J Healthc Eng; 2020 May 21; 2020():8862256. PubMed ID: 32802302
    [Abstract] [Full Text] [Related]

  • 20. Safety of Levosimendan in Pediatric Patients: An Up-to-Date Systematic Review.
    Pilia E, Silvetti S, Bohane SM, Pusceddu E, Belletti A, Collaborators.
    J Cardiothorac Vasc Anesth; 2024 Mar 21; 38(3):820-828. PubMed ID: 38135567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.